Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,015 | 67 | 240 | 157 | 1 |
| TOTAL | $1,503 | $481 | $553 | $678 | $304 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 532 | 0 |
| Other Non-Current Assets | 646 | 646 | 643 | 0 | 421 |
| TOTAL | $646 | $646 | $643 | $532 | $421 |
| Total Assets | $2,149 | $1,127 | $1,199 | $1,210 | $725 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,073 | N/A | N/A | 769 | N/A |
| Accounts payable and accrued liabilities | 973 | 2,617 | 2,741 | 2,597 | 2,605 |
| Accrued Expenses | 177 | 229 | 152 | 129 | 154 |
| Other current liabilities | 1,791 | 496 | 1,144 | 503 | 508 |
| TOTAL | $4,665 | $5,577 | $6,166 | $4,738 | $4,615 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,665 | $5,577 | $6,166 | $4,738 | $4,615 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,695 | 3,089 | 2,580 | 2,573 | 1,503 |
| Common Shares | 530 | 442 | 385 | 343 | 141 |
| Retained earnings | -17,646 | -15,620 | -14,719 | -11,862 | -9,598 |
| Other shareholders' equity | 839 | 0 | 0 | 0 | 0 |
| TOTAL | $-2,516 | $-4,449 | $-4,967 | $-3,528 | $-3,890 |
| Total Liabilities And Equity | $2,149 | $1,127 | $1,199 | $1,210 | $725 |